Status:

COMPLETED

NDPH Biomarker Study in Children and Adolescents

Lead Sponsor:

Duke University

Collaborating Sponsors:

International Headache Society

Conditions:

New Persistent Daily Headache

Eligibility:

All Genders

10-18 years

Brief Summary

This study will recruit pediatric patients with NDPH (New Daily Persistent Headache), characterize their headache in a standard manner, and treat the NDPH with standard medications used for treatment ...

Detailed Description

Subjects age 10-18 with diagnosis of NDPH (International Classification of Headache Disorders D ICHD-3 criteria) will be recruited for the study. Consenting subjects will receive standard headache car...

Eligibility Criteria

Inclusion

  • Patients between 10-18 yo with diagnosis of new daily persistent headache (ICHD-3 criteria) who have normal developmental history for age
  • Subject and parent legal guardian able to communicate in English, understand and consent to study
  • Subject will to undergo monthly injections at home for treatment of NDPH
  • Normal neuro imaging
  • No prior treatment with CGRP blocking medications or botulinum toxin

Exclusion

  • History of Reynauds syndrome
  • History of concussion or prior neurosurgery
  • Any structural brain lesion including hydrocephalus, congenital anomalies (including chiari malformation)
  • History of psychiatric disorders
  • History of any headache disorder (including migraine) prior to the diagnosis of NDPH
  • Pregnancy
  • Prior treatment with any CGRP blocking medication
  • Treatment with Botulinum toxin injections previously
  • Any other condition that in the opinion of the PI would interfere with the planned study treatment

Key Trial Info

Start Date :

April 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 29 2025

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT06018025

Start Date

April 15 2024

End Date

May 29 2025

Last Update

December 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Health System

Durham, North Carolina, United States, 27710